Cefuzonam
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (6R,7R)-7-([(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino)-8-oxo-3-(thiadiazol-5-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Identifiers | |
| CAS number | 82219-78-1 |
| ATC code | None |
| PubChem | CID 6336505 |
| ChemSpider | 4891670 |
| UNII | 860MT00T7T |
| KEGG | D03432 |
| Chemical data | |
| Formula | C16H15N7O5S4 |
| Mol. mass | 513.59 g/mol |
|
|
|
|
| |
|
Cefuzonam (INN) is a second-generation cephalosporin antibiotic.
References [edit]
- Hara K, Matsumoto F (December 1987). "[New antimicrobial agent series XXVIII: cefuzonam]". Jpn J Antibiot (in Japanese) 40 (12): 1953–63. PMID 3329242.
| This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||